|
Investors
Events & presentations
Corporate events 2009
- To print this page, please use the File menu or press simultaneously ctrl + p keys.
- Send this page
Sanofi-aventis organizes information meetings or conference calls for analysts and investors on the occasion of financial results publications and any other breaking news.
Acquisition of US-based Consumer Healthcare Company
December 21, 2009
 |
Senior management commented on “Creating a Strong U.S. Consumer Healthcare Platform” on the occasion of a conference call with the financial community.
|
Vaccines
December 17, 2009
 |
The seminar on Vaccines, organized by the Investor Relations, was held in Paris on December 17, 2009.
The presentation were followed by a Q&A session with the audience.
|
Third Quarter 2009 Results
October 30, 2009
 |
The results were reviewed by the management during a conference call.
The presentation was followed by a Q&A session.
|
Merial: Strengthening our Presence in Animal Health
July 30, 2009
 |
Discussed by the management during a conference call.
|
Second Quarter 2009 Results
July 29, 2009
 |
The results were reviewed by the management during a conference call.
The presentation was followed by a Q&A session
|
Emerging Markets
July 2, 2009
 |
The seminar on emerging markets, organized by Investor Relations, was held in Paris on July 2.
The presentations were followed by a Q&A session.
|
Lantus® Conference Call
June 29, 2009
 |
The conference call for the financial community was webcasted on June 29, 2009.
|
First Quarter 2009 Results
April 29, 2009
 |
The first quarter 2009 performance was reviewed by Chris Viehbacher - Chief Executive Officer, Marc Cluzel - Senior VP Research & Development, Hanspeter Spek - Executive VP Pharmaceutical Operations and Jérôme Contamine - Executive VP Chief Financial Officer. The presentation was followed by a Q&A session.
|
ACTIVE-A - Plavix® in Atrial Fibrillation (AF)
March 31, 2009
 |
The ACTIVE-A trial results and the opportunity for Plavix® were reviewed by Mr Jean-Pierre Lehner (Sr. Vice President, Chief Medical Officer) and Mr Pierre Chancel (Sr. Vice President Global Marketing & Access) respectively. The presentation was followed by a Q&A session.
|
2008 Full Year Results & Outlook
February 11, 2009
 |
2008 Full Year Results and Oultlook were reviewed by Mr. Chris Viehbacher, Chief Executive Officer, Mr Hanspeter Spek, Executive VP, Pharmaceutical Operations and Mrs Laurence Debroux, Senior Vice President, Chief Financial Officer.
The presentation was followed by a Q&A session with the audience.
|
|
Last update: July 30, 2010 10.40 AM (CET)
Quote: €44.48. Level change: -0.76%
Last update: July 29, 2010 04.12 PM (EST)Quote: $29.28. Level change: -0.01%
Further information
Publications
|
